Latest News: Proscia Receives FDA 510(k) Clearance For Concentriq AP-DxREAD THE PRESS RELEASE

Altasciences Chooses Proscia’s Digital Pathology Platform

By Author Proscia | March 21, 2023

Proscia announced that Altasciences has chosen Proscia’s Concentriq for Research to help its sponsors advance life-saving therapeutics. The CRO will deploy Proscia’s software platform to help advance faster, more complete preclinical development decisions.

Our website uses cookies. By using this site, you agree to its use of cookies.